These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26228287)
1. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration. Tagami T; Kubota M; Ozeki T J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287 [TBL] [Abstract][Full Text] [Related]
2. Fabrication of liposomal doxorubicin exhibiting ultrasensitivity against phospholipase A Tagami T; Ando Y; Ozeki T Int J Pharm; 2017 Jan; 517(1-2):35-41. PubMed ID: 27865984 [TBL] [Abstract][Full Text] [Related]
3. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. Tagami T; Ernsting MJ; Li SD J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149 [TBL] [Abstract][Full Text] [Related]
4. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227 [TBL] [Abstract][Full Text] [Related]
5. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. Tagami T; Ernsting MJ; Li SD J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635 [TBL] [Abstract][Full Text] [Related]
6. Polar Lipid Fraction E from Ayesa U; Chong PL Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182284 [TBL] [Abstract][Full Text] [Related]
8. A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells. Yavlovich A; Singh A; Blumenthal R; Puri A Biochim Biophys Acta; 2011 Jan; 1808(1):117-26. PubMed ID: 20691151 [TBL] [Abstract][Full Text] [Related]
9. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213 [TBL] [Abstract][Full Text] [Related]
10. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect. Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193 [TBL] [Abstract][Full Text] [Related]
11. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. Tagami T; May JP; Ernsting MJ; Li SD J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351 [TBL] [Abstract][Full Text] [Related]
12. Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant. Song H; Zhang J; Liu X; Deng T; Yao P; Zhou S; Yan W Pharm Dev Technol; 2016 Sep; 21(6):680-7. PubMed ID: 25975585 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines. Chen L; Alrbyawi H; Poudel I; Arnold RD; Babu RJ AAPS PharmSciTech; 2019 Feb; 20(3):99. PubMed ID: 30719596 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy. Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949 [TBL] [Abstract][Full Text] [Related]
15. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178 [TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response. Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464 [TBL] [Abstract][Full Text] [Related]
17. A novel two-step mild hyperthermia for advanced liposomal chemotherapy. Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966 [TBL] [Abstract][Full Text] [Related]
18. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo. Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618 [TBL] [Abstract][Full Text] [Related]
19. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275 [TBL] [Abstract][Full Text] [Related]
20. Characterization and cytotoxicity studies of DPPC:M(2+) novel delivery system for cisplatin thermosensitivity liposome with improving loading efficiency. Liu H; Zhang Y; Han Y; Zhao S; Wang L; Zhang Z; Wang J; Cheng J Colloids Surf B Biointerfaces; 2015 Jul; 131():12-20. PubMed ID: 25938850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]